Use of TrachPhone in Tracheostomized Patients
Launched by ATOS MEDICAL AB · Jul 2, 2024
Trial Information
Current as of May 01, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Tracheostomy patient outside critical care
- • Self-ventilating via a tracheostomy tube, independent of cuff status
- • 18 years or older
- Exclusion Criteria:
- • Patients with tidal volume beyond recommended range (50-1000 ml)
- • Dehydration
- • Very heavy/excessive secretion from the lungs and airways (requiring more frequently tracheal suction, more than hourly suctioning)
- • High oxygen need (FiO2 \> 0.4)
- • Acutely deteriorating patient
About Atos Medical Ab
Atos Medical AB is a leading global medical device company specializing in innovative solutions for patients who have undergone laryngectomy and other airway management challenges. With a strong commitment to enhancing quality of life, Atos Medical develops and markets a range of products, including voice rehabilitation devices and tracheostomy care solutions. The company is dedicated to advancing clinical research and fostering collaborations to improve patient outcomes, leveraging cutting-edge technology and a deep understanding of patient needs. Atos Medical is headquartered in Sweden and operates internationally, continually striving to set new standards in patient care and support for those with speech and breathing difficulties.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Patients applied
Trial Officials
Amanda Thomas, Dr
Principal Investigator
The Royal London Hospital, Barts Health NHS Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported